Musika wekambani, kushandiswa kwemabhiza nhasi
Stock quotes yekambani 71229 munguva chaiyo chaiye.
Musika wekambani, kushandiswa kwemabhiza nhasi

Stock quotes

Stock quotes online

Stock quotes history

Stock market capitalization

Stock Dividends

Kubatsira kubva kumakambani emakambani

Mishumo yemari

Rating share of companies. Ndekupi kwatingaisa mari?

Krystal Biotech, Inc. mutengo wemakesi

Nhamba yekutengeserana kwemabhizimisi Krystal Biotech, Inc. nhasi uye nhoroondo yemudzimai we Krystal Biotech, Inc. kubva pakutanga kwekutengeserana muKRYS mashizha mukutengesa.
Wedzera kune zvakasarudzwa
Yakawedzerwa kumajairika

Krystal Biotech, Inc. capitalization

Mazuva ano misika yemakemikari ye Krystal Biotech, Inc. is 2 215 679 232 US dhora.
-33 278 208 $ (-1.48%)
shanduko ye capitalization kubva zuro

Krystal Biotech, Inc. capitalization online nhasi mumadhora. Krystal Biotech, Inc. capitalization musika ndeyesese yezvose Krystal Biotech, Inc. mitengo yemitengo yakapihwa. Krystal Biotech, Inc. capitalization ishoko rakavhurika. Krystal Biotech, Inc. cap yekutengesa nhasi yakaenzana ne 2 215 679 232 US madhora.

Krystal Biotech, Inc. ivhu rekutengeserana

Nhasi kutengeswa kwezvikamu zve Krystal Biotech, Inc. zvakave 8 404 US dhora.
-88 701 $ (-91.35%)
kuchinja kwehuwandu hwebhizimisi kubvira zuro

Krystal Biotech, Inc. yekutengeserana yakawanda nhasi = 8 404 US madhora. Krystal Biotech, Inc. kutengeserana kunoitika pane dzakasiyana siyana zvekutengesa quote. Krystal Biotech, Inc. kutengeserana pamhepo kunoitirwa pamhepo kutengeserana kwakawanda pamhepo, webhusaiti yedu inoratidza huwandu hwekutengesa hwe Krystal Biotech, Inc. pazuva. Krystal Biotech, Inc. capitalization yakawa ne $ -33 278 208.

Ratidza:
Kuti

Krystal Biotech, Inc. musika wekodhi chati

Krystal Biotech, Inc. capitalization pagirazi nemakore. 0.31% pasvondo - shanduko mumusika capitalization ye Krystal Biotech, Inc.. 0% pamwedzi - shanduko mumusika wemusika we Krystal Biotech, Inc.. Krystal Biotech, Inc. capitalization inodonha pazuva pazuva mumadhora eUS.

Vhiki Mwedzi 3 months Gore 3 years

Krystal Biotech, Inc. capital capital history

Zuva Capitalization
Capitalization (mutengo capital) ndiyo kukosha kwemusika wezvikamu zvose zvekambani zvakatengeswa pamutengo wekutengesa. Market capitalization yakaenzana nemutengo wezvikamu zvinowanikwa nenhamba yezvikamu zvakakosha.
04/05/2023 2 215 679 232 $
03/05/2023 2 248 957 440 $
02/05/2023 2 197 387 008 $
01/05/2023 2 222 659 072 $
28/04/2023 2 186 556 160 $
27/04/2023 2 202 028 800 $
26/04/2023 2 208 862 464 $

Krystal Biotech, Inc. vhidhiyo chati

Vhiki Mwedzi 3 months Gore 3 years

Krystal Biotech, Inc. nhoroondo yemota data

Zuva Bhuku (24h)
Nhamba yekutengeserana yeKrystal Biotech, Inc. zvikamu ndeyewandu hwezvinhu zvose zvekutengeserana neKRYS zvikamu zvakatengwa uye zvinotengeswa panguva yakasarudzwa.
04/05/2023 8 404 $
03/05/2023 97 105 $
02/05/2023 26 729 $
01/05/2023 217 208 $
28/04/2023 47 238 $
27/04/2023 3 863 $
26/04/2023 89 690 $

Krystal Biotech, Inc. musika capitalization pa 04/05/2023 yakaenzana 2 215 679 232 US madhora. Musika capitalization ye Krystal Biotech, Inc. at 03/05/2023 zvakaenzana 2 248 957 440 US madhora. 02/05/2023 Krystal Biotech, Inc. musika capitalization yakaenzana 2 197 387 008 US madhora. 01/05/2023 Krystal Biotech, Inc. capitalization yakaenzana 2 222 659 072 US madhora.

28/04/2023 Krystal Biotech, Inc. musika capitalization yakaenzana 2 186 556 160 US madhora. Krystal Biotech, Inc. capitalization yakaenzana 2 202 028 800 US madhora pa 27/04/2023. 26/04/2023 Krystal Biotech, Inc. musika capitalization yakaenzana 2 208 862 464 US madhora.

Iko mari yepamusoro yeKrystal Biotech, Inc. nhasi ndeye 2 215 679 232 $. Imari yepamusi yeKrystal Biotech, Inc. yakachinja -1.48% inofananidzwa nezuro. Nhamba yekutengeserana ye KRYS nhengo dze Krystal Biotech, Inc. musi wekupedzisira wekutengesa yakava 8 404 $. Kutengeswa kwezvikamu zve Krystal Biotech, Inc. zvakachinjwa kusvika -91.345% zvichienzaniswa nezuva rekutanga rebhizimisi.

Mari yezvikamu Krystal Biotech, Inc.

Mari Krystal Biotech, Inc.